Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis

Journal of Cystic Fibrosis

Volumn 9, Issue 2, 2010, Pages 93-98

  Shead, Elizabeth F ^a   Haworth, Charles S ^b   Barker, Helen ^b   Bilton, Diana ^c   Compston, Juliet E ^d  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bone turnover; Cystic fibrosis; Cytokines; Osteoclasts; Osteoporosis

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; ANTIBIOTIC AGENT; COLLAGEN TYPE 1; CYTOKINE; INTERLEUKIN 6; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; FEMALE; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MALE; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT INFECTION; PROTEIN BLOOD LEVEL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION;

ADULT; BACTERIAL INFECTIONS; BONE REMODELING; CELL COUNT; COLLAGEN TYPE I; CYSTIC FIBROSIS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; OSTEOCALCIN; OSTEOCLASTS; OSTEOPROTEGERIN; PEPTIDES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 76749115215     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2009.11.007     Document Type: Article

References (30)

1. Haworth C., Selby P., Webb A., Dodd M., Musson H., McL Niven R., et al. Low bone mineral density in adults with cystic fibrosis. Thorax 54 11 (1999) 961-967
2. Conway S., Morton A., Oldroyd B., Truscott J., White H., Smith B., et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 55 9 (2000) 798-804
3. Elkin S., Fairney A., Burnett S., Kemp M., Kyd P., Burgess J., et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 12 5 (2001) 366-372
4. Aris R.M., Winders A.D., Buell H.E., Riggs D.B., Lester G.E., and Ontjes D.A. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med 128 3 (1998) 186-193
5. Ott S.M. Osteoporosis in patients with cystic fibrosis. Clin Chest Med 19 3 (1998) 555-567
6. Aris R., and Guise T.A. Cystic fibrosis and bone disease: are we missing a genetic link?. Europ Resp J 25 1 (2005) 9-11
7. Aris R., Stephens A., Ontjes D., Denene Blackwood A., Lark R., Hensler M., et al. Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med 162 5 (2000) 1674-1678
8. Ionescu A., Nixon L., Evans W., Stone M., Lewis-Jenkins V., Chatham K., et al. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 162 3 (2000) 789-794
9. Shead E., Haworth C.S., Gunn E., Bilton D., Scott M.A., and Compston J.E. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Am J Crit Care Med 174 3 (2006) 306-311
10. Saidenberg-Kermanach N., Bessis N., Cohen-Solal M., De Vernejoul M.C., and Boissier M.C. Osteoprotegerin and inflammation. Eur Cytokine Netw 13 2 (2002) 144-153
11. Tanaka Y., Nakayamada S., and Okada Y. Osteoblasts and osteoclasts in bone remodelling and inflammation. Curr Drug Targets Inflamm Allergy 4 3 (2005) 325-328
12. Xing L., Schwarz E.M., and Boyce B.F. Osteoclast precursors, RANKL/RANK, and immunology. Immunol Rev 208 (2005) 19-29
13. Clowes J., Riggs B.L., and Khosla S. The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 208 (2005) 207-227
14. Walsh N., Crotti T.N., Goldring S.R., and Gravallese E.M. Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 208 (2005) 228-251
15. O'Gradaigh D., Bord S., Ireland D., and Compston J.E. Osteoclastic bone resorption in rheumatoid arthritis and the acute-phase response. Rheumatol 41 11 (2003) 1429-1430
16. Walsh N., and Gravallese E.M. Bone loss in inflammatory arthritis: mechanisms and treatment strategies. Curr Opin Rheumatol 16 4 (2004) 419-427
17. Ehrlich L., and Roodman G.D. The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma. Immunol Rev 208 (2005) 252-266
18. Graves D., and Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 74 3 (2003) 391-401
19. Moschen A.R., Kaser A., Enrich B., Ludwiczek O., Gabriel M., Obrist P., et al. The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss. Gut 54 4 (2005) 479-487
20. Vestergaard P. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med 95 6 (2004) 469-480
21. Conway S. Impact of lung inflammation on bone metabolism in adolescents with cystic fibrosis. Paed Resp Rev 2 4 (2001) 324-331
22. Bell S., Bowerman A.M., Nixon L.E., Macdonald I.A., Elborn J.S., and Shale D.J. Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis. Eur J Clin Invest 30 (2000) 553-559
23. Haworth C., Selby P., Webb A., L. M., JS. E., Sharples L., et al. Inflammatory related changes in bone mineral content in adults with cystic fibrosis. Thorax 59 7 (2004) 613-617
24. Fuchs H., Borowitz D.S., and Christiansen D.H. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 331 (1994) 637-642
25. Beeton C.A., Bord S., Ireland D., and Compston J.E. Osteoclast formation and bone resorption are inhibited by megakaryocytes. Bone 39 5 (2006) 985-990
26. Boyce B.F., and Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473 (2008) 139-146
27. Jorgensen L, Skjelbakken T, Lochen ML, Ahmed L, Bjornerem A, Joakimsen R, et al. Anemia and the risk of non-vertebral fractures: the Tromso Study. Osteoporos Int 2009 Dec 3 (Electronic publication ahead of print).
28. Elkin S., Vedi S., Bord S., Garrahan N.J., Hodson M.E., and Compston J.E. Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis. Am J Respir Crit Care Med 166 11 (2002) 1470-1474
29. Perry M.G., Kirwan J.R., Jessop D.S., and Hunt L.P. Overnight variations in cortisol, interleukin 6, tumour necrosis factor a and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 68 (2009) 63-68
30. Shimizu M., Onoe Y., Mikumo M.H., Miyabara Y., Kuroda T., Yoshikata R., et al. Variations in circulating osteoprotegerin and soluble RANKL during diurnal and menstrual cycles in young women. Horm Res 71 (2009) 285-289